Show simple item record

dc.contributor.authorBowzyk Al-Naeeb, Anna
dc.contributor.authorAjithkumar, Thankamma
dc.contributor.authorBehan, Sarah
dc.contributor.authorHodson, Daniel
dc.date.accessioned2018-11-17T00:30:21Z
dc.date.available2018-11-17T00:30:21Z
dc.date.issued2018-08-22
dc.identifier.issn0959-8146
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/285328
dc.description.abstractThe term non-Hodgkin lymphoma (NHL) covers a spectrum of malignant disorders arising from cells of the immune system and manifesting predominantly as lymphadenopathy or solid tumour. The classification of NHL is complex and ever-evolving, with more than 50 different subtypes listed in the latest WHO classification of lymphoma (1). In this clinical update, we address the distinction between low-grade (indolent) and high-grade lymphoma, and discuss the principles of diagnosis and management that are of particular relevance to the non-specialist physician who may encounter patients with NHL during their initial presentation, during therapy and during periods of follow-up.
dc.languageeng
dc.publisherBMJ Publishing Group
dc.titleNon-Hodgkin lymphoma.
dc.typeArticle
prism.endingPagek3204
prism.publicationNameBritish Medical Journal
prism.startingPagek3204
prism.volume362
dc.identifier.doi10.17863/CAM.32699
dcterms.dateAccepted2018-06-22
rioxxterms.versionofrecord10.1136/bmj.k3204
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-06-22
dc.contributor.orcidHodson, Daniel [0000-0001-6225-2033]
dc.identifier.eissn1756-1833
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MC_PC_12009)
pubs.funder-project-idMedical Research Council (MR/M008584/1)
cam.issuedOnline2018-08-22
rioxxterms.freetoread.startdate2019-08-22


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record